Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system
about
MicroRNA-regulated viral vectors for gene therapyThe cardiac enigma: current conundrums in heart failure researchLight-based Approaches to Cardiac Arrhythmia Research: From Basic Science to Translational ApplicationsProof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platformOptogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations.Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.Novel Roles of GATA4/6 in the Postnatal Heart Identified through Temporally Controlled, Cardiomyocyte-Specific Gene Inactivation by Adeno-Associated Virus Delivery of Cre RecombinaseIntracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated CardiomyopathyGenome-wide RNAi screening identifies host restriction factors critical for in vivo AAV transductionThe Use of Gene Therapy for Ablation of Atrial Fibrillation.A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.Recombinant adeno-associated virus vectors in the treatment of rare diseases.Intramyocardial Injection of Recombinant Adeno-Associated Viral Vector Coexpressing PR39/Adrenomedullin Enhances Angiogenesis and Reduces Apoptosis in a Rat Myocardial Infarction Model.Evolving targeted therapies for right ventricular failure.miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.Use of Adeno-Associated Virus to Enrich Cardiomyocytes Derived from Human Stem Cells.Systemic gene transfer enables optogenetic pacing of mouse hearts.Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets.Heart failure with reduced ejection fraction.Manipulating the Proliferative Potential of Cardiomyocytes by Gene Transfer.Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus Vector.AAV Vectors for FRET-Based Analysis of Protein-Protein Interactions in Photoreceptor Outer Segments.Gene transfer to promote cardiac regeneration.Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart.Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations.The protective effect of activating Nrf2 / HO-1 signaling pathway on cardiomyocyte apoptosis after coronary microembolization in rats.In vivo selection of novel biotherapeutics.Optogenetic termination of atrial fibrillation in mice.Intravenous delivery of adeno-associated virus 9-encoded IGF-1Ea propeptide improves post-infarct cardiac remodelling.A step closer to cardiac optogenetics in vivo.VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.AAV9-mediated Rbm24 overexpression induces fibrosis in the mouse heart
P2860
Q26745822-35A07E92-6755-45E6-932B-7D28514AA239Q26766151-35F4BD88-8ADE-424B-96B1-7634566136CAQ28075299-31CCC5E6-4106-46DA-AA8B-FC02EBFF6393Q28596492-6FE232FD-7A8E-4984-A3FA-791CBD02706DQ30827638-ED9555DE-5F16-4D1C-A56A-C9C056E7EDA9Q35319305-C65EC4F3-DDB7-4572-B1B8-04E75151A4C8Q35646064-1EAF3E56-F4B1-4468-B461-CE52028EAD77Q35844633-E879084A-9C43-4052-BCAF-498D2D10C49DQ36056761-C96A56AF-8E58-45EA-AFAD-8267620BBD6CQ36458906-507204EF-4268-4AA3-9169-A173A9E30A4AQ36483327-7B1F2CF4-68B7-4294-B684-85E90CE5FE7EQ36598414-26642DCE-A76E-4675-8296-AA5CC4C1FBC7Q37279525-645C28E3-CDFD-4EF0-9594-5B86C3E35177Q37703477-2B9B1738-32C9-4CCD-BC16-833672167AFFQ38559308-781CECAF-59D3-4F39-ACCD-90660B760460Q38591803-FD3250DE-5625-4367-BD17-9A1DA1AAA80AQ38845573-AEB30598-A226-45F2-83A6-03A71D93732EQ39059136-7600F727-1BC3-4D33-BF0A-33AF7514D68DQ39332410-95F34AD9-F15A-4018-AFA7-993150D13529Q40081533-601C4ACB-9550-4D75-99CC-D41600C24070Q40322654-3500F1B8-22A4-4005-A347-3FB8D0A0D155Q40363166-87256BC8-A597-40F1-BC98-7FD98D3A3C17Q40624978-ADB8F532-2E19-4E8B-943B-7C5401AAE40DQ40802294-508B3FAD-158A-4F0A-AE01-76FB4A0186A5Q41021093-E21C0CB2-2BF0-4E25-9618-A8157A307941Q41671504-38555F57-9DA6-4637-9BB8-1E352DB0B256Q42633714-A2C9318A-37D5-4796-A787-305881456126Q42666156-39E4CAE3-1982-4FCF-885F-2061810F5C58Q47558940-9B91B49B-24B3-4444-988A-A19E017EFA90Q50852666-8CBC0DB9-CCBB-4DB1-9BB0-C3E410ED273AQ51040280-3C7B3A4D-ED38-4067-8C76-69928B20AEC6Q55546604-3818AD16-3462-43EB-947F-25D576791F16Q58802404-2D08653A-937C-4E00-AD43-9307762224AC
P2860
Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Adeno-associated virus vectors ...... s in the cardiovascular system
@ast
Adeno-associated virus vectors ...... s in the cardiovascular system
@en
Adeno-associated virus vectors ...... s in the cardiovascular system
@nl
type
label
Adeno-associated virus vectors ...... s in the cardiovascular system
@ast
Adeno-associated virus vectors ...... s in the cardiovascular system
@en
Adeno-associated virus vectors ...... s in the cardiovascular system
@nl
prefLabel
Adeno-associated virus vectors ...... s in the cardiovascular system
@ast
Adeno-associated virus vectors ...... s in the cardiovascular system
@en
Adeno-associated virus vectors ...... s in the cardiovascular system
@nl
P3181
P1433
P1476
Adeno-associated virus vectors ...... s in the cardiovascular system
@en
P2093
Lorena Zentilin
P304
P3181
P356
10.1161/CIRCRESAHA.114.302331
P407
P577
2014-05-01T00:00:00Z